Back
TB

TRex Bio,

TRXB

Biotech & Healthcare · NASDAQ · IPO October 9, 2026

Biotech & Healthcare
Website unavailable

01

Company Overview

TRex Bio, is filing to list on NASDAQ Global Select. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.

TRex Bio, is going public on NASDAQ Global Select on 2026-10-09. Offering 8,333,334 shares.

Recent headlines

Couldn't pull live headlines right now.

02

AI Analysis

Possible growth narrative

Sits adjacent to Biotech & Healthcare — themes that are currently drawing meaningful capital and attention.

Risks

Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.

Volatility

Expect elevated price volatility in the first weeks of trading as supply and demand find balance.

Market attention

Recently listed — monitoring early trading activity and analyst initiations.

Educational summary only. Not investment advice.

03

Related Themes

Biotech & Healthcare

04

IPO Information

IPO date
October 9, 2026
Exchange
NASDAQ
Status
Recently Listed
Industry
Biotech & Healthcare
Valuation
$116.7M raise
Headquarters
—
Attention score
61 / 100
Ticker
TRXB